Credible, creditable


Union Budget 2026–27: "Credible, Creditable"

UPSC Prelims + Mains Study Note


1. At a Glance


2. Why in the News


3. Background & Evolution


4. Core Static Facts

Parameter Detail
Budget presented by FM Nirmala Sitharaman
Date of presentation 1 February 2026
Fiscal Deficit (BE 2026–27) 4.3% of GDP [S2]
Presenting Ministry Ministry of Finance
Seven strategic manufacturing sectors Biopharma, Semiconductors, Electronics, Rare Earths, Chemicals, Capital Goods, Textiles [S3]
Biopharma SHAKTI allocation ₹10,000 crore over 5 years [S1][S4]
Biopharma SHAKTI objective Global hub for biologics/biosimilars; 3 new/upgraded NIPERs; 1,000+ clinical trial sites [S1]
India Semiconductor Mission 2.0 Equipment, materials, full-stack Indian IP, industry-led R&D [S3]
Electronics Component Manufacturing Scheme Increased allocation (follow-up to existing PLI) [S3]
Rare Earth Corridors Target states: Odisha, Kerala, Andhra Pradesh, Tamil Nadu [S2]
Textile sector measures National Fibre Scheme, Textile Expansion & Employment Scheme, Mega Textile Parks [S2]
Leather sector Duty-free import of inputs; export obligation extended from 6 months → 12 months [S2]
Pharmaceuticals (context) Exempt from U.S. 50% tariffs; already globally competitive [S4]

5. Multi-Dimensional Analysis

Economic

Social / Labour

Geopolitical / Strategic

Scientific / Technological

Environmental

Administrative / Governance


6. Recent Developments (last 12–18 months)


7. Prelims Hooks

  1. Fiscal deficit target in Union Budget 2026–27: 4.3% of GDP. [S2]
  2. Biopharma SHAKTI is a scheme under Budget 2026–27 with an outlay of ₹10,000 crore over five years. [S1]
  3. The scheme aims to make India a global biologics and biosimilars manufacturing hub; it also includes 3 new/upgraded NIPERs and 1,000+ clinical trial sites. [S1]
  4. Seven strategic manufacturing sectors targeted in Budget 2026–27: Biopharma, Semiconductors, Electronics, Rare Earths, Chemicals, Capital Goods, Textiles. [S3]
  5. India Semiconductor Mission 2.0 focuses on equipment, materials, full-stack Indian IP design, and industry-led R&D. [S3]
  6. Rare Earth Corridors proposed in four states: Odisha, Kerala, Andhra Pradesh, Tamil Nadu. [S2]
  7. Export obligation period extended from 6 months to 12 months for exporters of leather garments, textile garments, and footwear using duty-free imported inputs. [S2]
  8. Electronics Component Manufacturing Scheme — existing scheme with increased allocation under Budget 2026–27 (follow-up to earlier PLI). [S3]
  9. Textile PLI remains operational up to FY 2029–30, covering MMF apparel, fabrics, and technical textiles. [S2]
  10. Budget 2026–27 explicitly contrasts with Budget 2025–26, which was dominated by income-tax rate and slab relaxations. [S4]
  11. Mega Textile Parks are to be set up in challenge mode — a competitive state-level allocation process. [S2]
  12. National Fibre Scheme covers natural fibres (silk, wool, jute), man-made fibres, and new-age fibres. [S2]
  13. Indian pharmaceuticals are exempt from U.S. 50% tariffs — cited as rationale for Biopharma SHAKTI investment. [S4]
  14. Implementing agency for semiconductor initiatives: Ministry of Electronics and Information Technology (MeitY). [S3]

8. Mains Relevance

GS Paper(s): GS-III (Indian Economy, Mobilization of Resources, Inclusive Growth, Government Budgeting)

Specific Syllabus Headings: - Effects of liberalisation on the economy; industrial growth and policy - Government Budgeting - Infrastructure (manufacturing ecosystems) - Science and Technology — developments and applications (semiconductors, biopharma)

Plausible Mains Question Stems: 1. "Union Budget 2026–27 has been described as 'credible and creditable' for choosing prudence over populism. Critically examine the Budget's approach to manufacturing competitiveness in the context of evolving global trade dynamics." 2. "Evaluate the strategic significance of India's push into semiconductor and biopharma manufacturing through Budget 2026–27 allocations. What structural challenges must India address to realise these ambitions?" 3. "The expansion of Rare Earth Corridors in Budget 2026–27 has both strategic and environmental dimensions. Discuss."


9. Related Topics to Study Next

Topic Connection
Production Linked Incentive (PLI) Schemes Direct predecessor/framework for all 7 sectoral pushes in Budget 2026–27
India Semiconductor Mission (ISM 1.0 & 2.0) Core strategic programme deepened in this budget
Critical Minerals and Rare Earths Policy Rare Earth Corridors link to National Critical Mineral Mission
CDSCO and Drug Regulation in India Biopharma SHAKTI strengthens CDSCO; relevant for GS-II governance
Fiscal Federalism in India Challenge mode for Textile Parks; state competition for central scheme funds
India–US Trade Relations & Tariff Policy Tariff exemptions for pharma; U.S. 50% tariff context of geopolitical uncertainty
MSME and Employment in India Textiles/leather measures target labour-intensive MSME clusters
National Education Policy & NIPERs Biopharma SHAKTI's 3 new NIPERs links education infrastructure to industrial policy

10. Common Errors / Trap Areas

  1. Confusing ISM 1.0 vs ISM 2.0: ISM 1.0 focused on incentivising fab production and assembly; ISM 2.0 adds equipment, materials, and Indian IP design — a qualitative shift, not just a budget increase.
  2. Biopharma SHAKTI vs Pharma PLI: Pharma already has a separate PLI scheme. SHAKTI is specifically for biologics/biosimilars — not generic small-molecule drugs. Do not conflate.
  3. Fiscal deficit figure: 4.3% is the Budget Estimate (BE); aspirants often confuse BE with Revised Estimate (RE) or Actuals from prior years.
  4. Rare Earth states: All four are coastal/peninsular states — not landlocked mineral-belt states like Jharkhand/Chhattisgarh. The distinction matters for forest/tribal rights context.
  5. "Challenge mode" for Textile Parks: This is NOT the same as an open tender or auction — it is a competitive application process among states, similar to Smart Cities Mission selection methodology. Do not describe it as privatisation.

11. Sources